International Journal for Parasitology: Drugs and Drug Resistance
CYP51 structures and structure-based development of novel, pathogen-specific inhibitory scaffoldsTRP channels in schistosomesScreening of the 'Pathogen Box' identifies an approved pesticide with major anthelmintic activity against the barber's pole wormThe malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugsRepurposing drugs for the treatment and control of helminth infectionsDrug resistance analysis by next generation sequencing in LeishmaniaIs anthelmintic resistance a concern for the control of human soil-transmitted helminths?Drug repurposing and human parasitic protozoan diseasesGlobal analysis of Plasmodium falciparum Na(+)/H(+) exchanger (pfnhe-1) allele polymorphism and its usefulness as a marker of in vitro resistance to quinineResearch for new drugs for elimination of onchocerciasis in AfricaAnthelmintics: From discovery to resistance II (San Diego, 2016)Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal KenyaWIPO Re:Search: Accelerating anthelmintic development through cross-sector partnershipsInvestigating the antiplasmodial activity of primary sulfonamide compounds identified in open source malaria dataInsecticidal activities of histone deacetylase inhibitors against a dipteran parasite of sheep, Lucilia cuprinaMetabolic profiling and in vitro assessment of anthelmintic fractions of Picria fel-terrae LourSesquiterpene lactone containing extracts from two cultivars of forage chicory (Cichorium intybus) show distinctive chemical profiles and in vitro activity against Ostertagia ostertagiScaffold proteins LACK and TRACK as potential drug targets in kinetoplastid parasites: Development of inhibitorsReverse pharmacology for developing an anti-malarial phytomedicine. The example of Argemone mexicana.Recent highlights in anti-protozoan drug development and resistance research.The Entamoeba histolytica serum-inducible transmembrane kinase EhTMKB1-9 is involved in intestinal amebiasisIdentification of β-hematin inhibitors in a high-throughput screening effort reveals scaffolds with in vitro antimalarial activity.The Vivax Surveyor: Online mapping database for Plasmodium vivax clinical trialsInvestigating anthelmintic efficacy against gastrointestinal nematodes in cattle by considering appropriate probability distributions for faecal egg count data.The establishment of in vitro culture and drug screening systems for a newly isolated strain of Trypanosoma equiperdum.Functional and genetic evidence that nucleoside transport is highly conserved in Leishmania species: Implications for pyrimidine-based chemotherapy.Polymorphism in ABC transporter genes of Dirofilaria immitis.Elimination of Schistosoma mansoni in infected mice by slow release of artemisone.Progressive increase in point mutations associates chloroquine resistance: Even after withdrawal of chloroquine use in IndiaReduced efficacy of albendazole against Ascaris lumbricoides in Rwandan schoolchildren.High level expression of a glutamate-gated chloride channel gene in reproductive tissues of Brugia malayi may explain the sterilizing effect of ivermectin on filarial worms.Idiosyncratic quinoline central nervous system toxicity: Historical insights into the chronic neurological sequelae of mefloquine.Uptake of benzimidazoles by Trichuris suis in vivo in pigs.microRNAs of parasitic helminths - Identification, characterization and potential as drug targets.Moxidectin and the avermectins: Consanguinity but not identity.Repurposing of approved drugs from the human pharmacopoeia to target Wolbachia endosymbionts of onchocerciasis and lymphatic filariasis.Compound library screening identified Akt/PKB kinase pathway inhibitors as potential key molecules for the development of new chemotherapeutics against schistosomiasis.Tyrosine aminotransferase from Leishmania infantum: A new drug target candidatePraziquantel sensitivity of Kenyan Schistosoma mansoni isolates and the generation of a laboratory strain with reduced susceptibility to the drug.Comparative pharmacology of flatworm and roundworm glutamate-gated chloride channels: Implications for potential anthelmintics.
P1433
Q24605691-CE3EFB87-B9B2-48E6-93B5-FED25233B752Q26738732-9E4509E6-9EED-453D-8831-D0F2A7AFAB94Q26741549-6809BE1D-277A-411B-BC09-4B95EC1C2608Q26781634-11D328F9-1FC2-4518-A8B0-3C7C156B351FQ26823355-DA950C4F-E0D1-4680-A17E-FF1A4A9CC7C5Q26851222-C1B9C093-F29B-441F-B243-207DC495D205Q26991607-0A832483-42C4-47A5-834B-B12D5E84D7FCQ26999453-A7EAB41F-5CB3-4FD5-89BD-C6E6DF4A10B8Q27012884-A00342F3-92DB-4CAD-87C5-76F1B1A35855Q28066402-699B5A86-26E9-414C-BB17-FED16538AF45Q28074571-7313CCDD-1E03-4424-BEAE-348DCC4FF50AQ28125914-F7BB3954-4FFB-428A-9D25-5CC777E7A24DQ28254042-8F77D4C4-C299-4F50-A36B-7BFB7433D433Q28818002-13778241-AF22-48D9-B276-841705AA894DQ28818731-5C2056A4-4B0E-4E61-A4AF-14BE3C97F638Q28829555-4BDDE73B-7A8F-484A-AB12-2DCEDA3B7A0CQ28834099-52A978DE-6D3E-4CFF-A5F9-EA05960CF9B2Q30359734-9599AA27-7739-4795-967E-DCCEEA958777Q30389997-3532FBAA-B368-4E36-BB8C-F5E1F746A38CQ30414810-A1BE79B2-6873-47FF-8B17-AB492C2F98F4Q30416057-075D5411-5A9B-45EF-9D85-1AEB53EBC2E6Q30422848-92EECB18-A621-4A90-BE1B-7BAEDE76A810Q30491343-E301A287-DA7D-486E-843F-4DF5BA963926Q31159615-CE10C31E-51CE-4AB3-B540-A94C69168125Q33599669-44FB2A38-9A96-446B-9432-80FC8BEBEDECQ33610259-BB27CE8B-4ACC-418E-8B62-23860C7E4B4DQ33648348-C2175516-1E05-43B9-98D8-4E83E57FB121Q33681103-199BBC6E-A9E3-45EF-A2CC-4F3FECCE02EEQ33889755-347D424E-241F-408E-95D5-0A495FD40049Q33889760-84E4046D-3C9A-4985-A50F-53461FDEED00Q33892012-EDF33E82-BD19-404B-BE26-F47E258A7200Q33892018-D24AA138-8FBA-4E89-BD13-CB4886865B17Q33892022-51C8C253-44B5-41AD-B4C3-B7C168034FF4Q33892045-EFCA6BAB-B920-4ECB-ADCF-7A06D0DE5EFAQ34404748-E22B3631-BE2F-482A-B089-D67E7772E7B1Q34454263-06B3DA8F-0AEB-44FB-9607-90FE8628D726Q34705415-526D1809-7000-492D-AF26-B38D082D0F7DQ34705430-371D87B3-9907-412D-83A9-C6FFF1FF5030Q34705447-89A644CE-717C-4831-87A9-36A2F91504D7Q34705499-E1BDF9AC-6897-4EAC-AD27-9A22F1A5CDD6
P1433
International Journal for Parasitology: Drugs and Drug Resistance
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Elsevier
@nl
wissenschaftliche Fachzeitschrift
@de
name
International Journal for Parasitology: Drugs and Drug Resistance
@de
International Journal for Parasitology: Drugs and Drug Resistance
@en
International Journal for Parasitology: Drugs and Drug Resistance
@es
International Journal for Parasitology: Drugs and Drug Resistance
@it
International Journal for Parasitology: Drugs and Drug Resistance
@nl
type
label
International Journal for Parasitology: Drugs and Drug Resistance
@de
International Journal for Parasitology: Drugs and Drug Resistance
@en
International Journal for Parasitology: Drugs and Drug Resistance
@es
International Journal for Parasitology: Drugs and Drug Resistance
@it
International Journal for Parasitology: Drugs and Drug Resistance
@nl
prefLabel
International Journal for Parasitology: Drugs and Drug Resistance
@de
International Journal for Parasitology: Drugs and Drug Resistance
@en
International Journal for Parasitology: Drugs and Drug Resistance
@es
International Journal for Parasitology: Drugs and Drug Resistance
@it
International Journal for Parasitology: Drugs and Drug Resistance
@nl
P31
P3181
P4616
P1055
P1058
P1156
21100197941
P123
P1476
International Journal for Parasitology: Drugs and Drug Resistance
@en
P236
P3181
P407
P5115
P571
2011-01-01T00:00:00Z
P5963
international-journal-for-parasitology-drugs-and-drug-resistance